Orthofix Medical Inc. (NASDAQ:OFIX) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA reduced its position in shares of Orthofix Medical Inc. (NASDAQ:OFIXFree Report) by 16.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 83,662 shares of the medical device company’s stock after selling 16,960 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.23% of Orthofix Medical worth $1,076,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Swiss National Bank grew its stake in Orthofix Medical by 1.3% during the 3rd quarter. Swiss National Bank now owns 76,400 shares of the medical device company’s stock valued at $983,000 after acquiring an additional 1,000 shares in the last quarter. Boston Partners grew its holdings in shares of Orthofix Medical by 22.2% during the 3rd quarter. Boston Partners now owns 41,853 shares of the medical device company’s stock valued at $538,000 after acquiring an additional 7,600 shares in the last quarter. Great Lakes Advisors LLC increased its stake in shares of Orthofix Medical by 12.4% in the third quarter. Great Lakes Advisors LLC now owns 280,055 shares of the medical device company’s stock worth $3,602,000 after acquiring an additional 30,890 shares during the last quarter. Illinois Municipal Retirement Fund purchased a new stake in shares of Orthofix Medical during the third quarter worth $288,000. Finally, Versor Investments LP acquired a new stake in Orthofix Medical during the third quarter valued at $186,000. Hedge funds and other institutional investors own 89.76% of the company’s stock.

Orthofix Medical Trading Down 0.1 %

Orthofix Medical stock opened at $14.40 on Tuesday. Orthofix Medical Inc. has a one year low of $9.57 and a one year high of $21.75. The company’s fifty day moving average price is $13.44 and its two-hundred day moving average price is $14.07. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.58 and a quick ratio of 1.13. The company has a market capitalization of $529.34 million, a price-to-earnings ratio of -3.69 and a beta of 1.06.

Analyst Upgrades and Downgrades

OFIX has been the subject of a number of recent research reports. StockNews.com raised Orthofix Medical from a “sell” rating to a “hold” rating in a research note on Tuesday, February 6th. Roth Mkm initiated coverage on shares of Orthofix Medical in a research note on Friday, October 20th. They issued a “neutral” rating and a $12.00 target price for the company.

Check Out Our Latest Stock Analysis on Orthofix Medical

Orthofix Medical Profile

(Free Report)

Orthofix Medical Inc operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions.

Featured Articles

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix Medical Inc. (NASDAQ:OFIXFree Report).

Institutional Ownership by Quarter for Orthofix Medical (NASDAQ:OFIX)

Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.